We are live on ! Find out more
CTC

Central Trust Company Portfolio holdings

AUM $5.53B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+28.94%
3 Year Est. Return
+83.96%
5 Year Est. Return
+104.85%
10 Year Est. Return
+351.46%
AUM
$4.02B
AUM Growth
+$254M
Cap. Flow
-$10.4M
Cap. Flow %
-0.26%
Top 10 Hldgs %
29.83%
Holding
1,434
New
56
Increased
252
Reduced
492
Closed
64

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.43%
2 Technology 15.74%
3 Healthcare 7.08%
4 Consumer Discretionary 6.41%
5 Financials 5.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IGC icon
1351
IGC Pharma
IGC
$29.1M
$360 ﹤0.01%
+900
New +$279
SIDU icon
1352
Sidus Space
SIDU
$208M
$339 ﹤0.01%
+100
New +$624
DOMO icon
1353
Domo
DOMO
$177M
$331 ﹤0.01%
37
CHPT icon
1354
ChargePoint
CHPT
$241M
$308 ﹤0.01%
8
-5
-38% -$196
TLRY icon
1355
Tilray
TLRY
$576M
$297 ﹤0.01%
12
NVCR icon
1356
NovoCure
NVCR
$1.82B
$282 ﹤0.01%
18
CNXC icon
1357
Concentrix
CNXC
$1.65B
$265 ﹤0.01%
4
TELL
1358
DELISTED
Tellurian Inc.
TELL
$265 ﹤0.01%
400
RVNC
1359
DELISTED
Revance Therapeutics, Inc.
RVNC
$246 ﹤0.01%
50
ADNT icon
1360
Adient
ADNT
$1.41B
$231 ﹤0.01%
7
PCG icon
1361
PG&E
PCG
$31.3B
$218 ﹤0.01%
13
GH icon
1362
Guardant Health
GH
$21.8B
$186 ﹤0.01%
9
BFH icon
1363
Bread Financial
BFH
$4.12B
$149 ﹤0.01%
4
VTVT icon
1364
vTv Therapeutics
VTVT
$132M
$118 ﹤0.01%
+5
New +$64
MURA
1365
DELISTED
Mural Oncology
MURA
$45 ﹤0.01%
9
LCTX icon
1366
Lineage Cell Therapeutics
LCTX
$260M
$43 ﹤0.01%
29
HELP
1367
Cybin Inc
HELP
$1,000M
$42 ﹤0.01%
3
WB icon
1368
Weibo
WB
$1.63B
$37 ﹤0.01%
4
TCRT icon
1369
Alaunos Therapeutics
TCRT
$3.96M
$19 ﹤0.01%
+1
New +$20
GOEV
1370
DELISTED
Canoo Inc. Class A Common Stock
GOEV
-4
Closed -$279
TNXP icon
1371
Tonix Pharmaceuticals
TNXP
$220M
0
ABM icon
1372
ABM Industries
ABM
$2.92B
-45
Closed -$2.02K
ACNB icon
1373
ACNB Corp
ACNB
$654M
-153
Closed -$6.85K
AGM icon
1374
Federal Agricultural Mortgage
AGM
$2.44B
-21
Closed -$4.02K
AGNC icon
1375
AGNC Investment
AGNC
$12.4B
-4,678
Closed -$45.9K

Similar funds

Central Trust Company's Q1 2024 Portfolio in Review

As of Q1 2024, Central Trust Company held 1,434 positions worth $4.02B, up 6.7% from $3.76B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Central Trust Company's Q1 2024 filing shows 56 new, 252 increased, 492 reduced and 64 closed positions. Its largest new stake was JPMorgan Hedged Equity Laddered Overlay ETF: 190,043 shares worth $10.6M. The largest sale was JPMorgan Equity Premium Income ETF, an estimated $11.9M.

By sector, the portfolio is most concentrated in Miscellaneous at 46% of assets, up from 46% a quarter earlier, followed by Technology and Healthcare.

  • Central Trust Company's largest Q1 2024 buy was JPMorgan Hedged Equity Laddered Overlay ETF: 190,043 shares worth $10.6M.
  • Central Trust Company added most to Schwab US TIPS ETF in Q1 2024, an estimated $13.9M increase.
  • Central Trust Company's biggest Q1 2024 reduction was JPMorgan Equity Premium Income ETF, cutting an estimated $11.9M.
  • Central Trust Company fully exited Vanguard Long-Term Corporate Bond ETF in Q1 2024, selling an estimated $1.15M.
  • Central Trust Company's ten largest holdings make up 30% of its $4.02B portfolio in Q1 2024.
  • Central Trust Company opened 56 new positions and closed 64 in Q1 2024.
  • Central Trust Company's portfolio value rose 6.7% quarter-over-quarter to $4.02B.

Based on Central Trust Company's 13F filing for Q1 2024, filed 24 Apr 2024.